on October 13, 2005
Published online before print October 13, 2005, doi: 10.1161/01.ATV.0000190610.63878.20
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 25, 2005
Accepted on September 11, 2005
Tumor Necrosis Factor-
-Induced Iron Sequestration and Oxidative Stress in Human Endothelial Cells
Masayoshi Nanami *;
From the Department of Internal Medicine, Division of Kidney and Dialysis (M.N., Y.O., K.I., R.M., K.M., Y.K., M.I., T.N.) and the Department of Biochemistry (T.O., H.E., K.S), Hyogo College of Medicine, Hyogo, Japan.
* To whom correspondence should be addressed. E-mail: m-nanami{at}hyo-med.ac.jp.
Objective--Tumor necrosis factor (TNF)-
-induced endothelial injury, which is associated with atherosclerosis, is mediated by intracellular reactive oxygen species. Iron is essential for the amplification of oxidative stress. We tested whether TNF- accelerated iron accumulation in vascular endothelium, favoring synthesis of hydroxyl radical.
Methods and Results--Diverse iron transporters, including iron import proteins (transferrin receptor [TfR] and divalent metal transporter 1 [DMT1]) and an iron export protein (ferroportin 1 [FP1]) coexist in human umbilical endothelial cells (HUVECs). TNF- caused upregulation of TfR and DMT1 and downregulation of FP1, which were demonstrated in mRNA as well as protein levels. These changes in iron transporters were accompanied by accumulation of iron that was both transferrin-dependent and transferrin-independent. Modifications of these mRNAs were regulated post-transcriptionally, and were coordinated with activation of binding activity of iron regulatory protein 1 to the iron responsive element on transporter mRNAs. Using a salicylate trap method, we observed that only simultaneous exposure of endothelial cells to iron and TNF- accelerated hydroxyl radical production.
Conclusions--TNF- could cause intracellular iron sequestration, which may participate importantly in the pathophysiology of atherosclerosis and cardiovascular disease.
Key words: cytokines • endothelium • free radicals • inflammation • iron
This article has been cited by other articles:
 |
|
 |
|
  J. Salazar, N. Mena, S. Hunot, A. Prigent, D. Alvarez-Fischer, M. Arredondo, C. Duyckaerts, V. Sazdovitch, L. Zhao, L. M. Garrick, et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease PNAS, November 25, 2008; 105(47): 18578 - 18583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. l. Sullivan Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability Experimental Biology and Medicine, September 1, 2007; 232(8): 1014 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Constante, D. Wang, V.-A. Raymond, M. Bilodeau, and M. M. Santos Repression of Repulsive Guidance Molecule C during Inflammation Is Independent of Hfe and Involves Tumor Necrosis Factor-{alpha} Am. J. Pathol., February 1, 2007; 170(2): 497 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Li and B. Frei Iron Chelation Inhibits NF-{kappa}B-Mediated Adhesion Molecule Expression by Inhibiting p22phox Protein Expression and NADPH Oxidase Activity Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2638 - 2643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and M. A. Perrella Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases? Circulation, November 14, 2006; 114(20): 2178 - 2189. [Full Text] [PDF]
|
|